JP5424528B2 - 微弱光サンプルの解析方法および装置 - Google Patents
微弱光サンプルの解析方法および装置 Download PDFInfo
- Publication number
- JP5424528B2 JP5424528B2 JP2006273442A JP2006273442A JP5424528B2 JP 5424528 B2 JP5424528 B2 JP 5424528B2 JP 2006273442 A JP2006273442 A JP 2006273442A JP 2006273442 A JP2006273442 A JP 2006273442A JP 5424528 B2 JP5424528 B2 JP 5424528B2
- Authority
- JP
- Japan
- Prior art keywords
- image
- fluorescence
- cell
- sample
- luminescence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims description 104
- 238000004020 luminiscence type Methods 0.000 claims description 326
- 108090000623 proteins and genes Proteins 0.000 claims description 289
- 238000003384 imaging method Methods 0.000 claims description 248
- 238000005259 measurement Methods 0.000 claims description 163
- 238000002073 fluorescence micrograph Methods 0.000 claims description 126
- 230000003287 optical effect Effects 0.000 claims description 122
- 102000006830 Luminescent Proteins Human genes 0.000 claims description 60
- 108010047357 Luminescent Proteins Proteins 0.000 claims description 60
- 238000004458 analytical method Methods 0.000 claims description 47
- 108091006047 fluorescent proteins Proteins 0.000 claims description 22
- 102000034287 fluorescent proteins Human genes 0.000 claims description 22
- 210000001161 mammalian embryo Anatomy 0.000 claims description 13
- 210000004027 cell Anatomy 0.000 description 407
- 239000000523 sample Substances 0.000 description 256
- 230000014509 gene expression Effects 0.000 description 184
- 230000022131 cell cycle Effects 0.000 description 139
- 230000005284 excitation Effects 0.000 description 104
- 238000005286 illumination Methods 0.000 description 75
- 238000004891 communication Methods 0.000 description 64
- 108060001084 Luciferase Proteins 0.000 description 56
- 238000010586 diagram Methods 0.000 description 42
- 238000000799 fluorescence microscopy Methods 0.000 description 39
- 239000005089 Luciferase Substances 0.000 description 38
- 230000004927 fusion Effects 0.000 description 38
- 239000013598 vector Substances 0.000 description 37
- 239000003153 chemical reaction reagent Substances 0.000 description 32
- 230000000694 effects Effects 0.000 description 32
- 238000012545 processing Methods 0.000 description 30
- 239000000126 substance Substances 0.000 description 30
- 239000000758 substrate Substances 0.000 description 27
- 230000008569 process Effects 0.000 description 24
- 238000000691 measurement method Methods 0.000 description 23
- 238000003860 storage Methods 0.000 description 21
- 230000005540 biological transmission Effects 0.000 description 20
- 210000003470 mitochondria Anatomy 0.000 description 20
- 230000008859 change Effects 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 17
- 230000004807 localization Effects 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 16
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 15
- 230000007704 transition Effects 0.000 description 15
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 14
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 14
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 14
- 210000000170 cell membrane Anatomy 0.000 description 12
- 210000000805 cytoplasm Anatomy 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 239000013600 plasmid vector Substances 0.000 description 12
- 239000003086 colorant Substances 0.000 description 11
- 238000012632 fluorescent imaging Methods 0.000 description 11
- 210000004940 nucleus Anatomy 0.000 description 10
- 230000033764 rhythmic process Effects 0.000 description 10
- 239000007850 fluorescent dye Substances 0.000 description 9
- 238000011002 quantification Methods 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- 238000005415 bioluminescence Methods 0.000 description 8
- 230000029918 bioluminescence Effects 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 230000003834 intracellular effect Effects 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 239000012620 biological material Substances 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000007774 longterm Effects 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 210000002569 neuron Anatomy 0.000 description 7
- 230000001360 synchronised effect Effects 0.000 description 7
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 6
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 6
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 6
- 239000007995 HEPES buffer Substances 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000005090 green fluorescent protein Substances 0.000 description 6
- 230000001678 irradiating effect Effects 0.000 description 6
- 239000003446 ligand Substances 0.000 description 6
- 210000001747 pupil Anatomy 0.000 description 6
- 230000001172 regenerating effect Effects 0.000 description 6
- 230000003595 spectral effect Effects 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- 229910052724 xenon Inorganic materials 0.000 description 6
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 230000002438 mitochondrial effect Effects 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 108700026220 vif Genes Proteins 0.000 description 5
- 101150038243 CLOCK gene Proteins 0.000 description 4
- 102000016736 Cyclin Human genes 0.000 description 4
- 108050006400 Cyclin Proteins 0.000 description 4
- 108010058545 Cyclin D3 Proteins 0.000 description 4
- 102100037859 G1/S-specific cyclin-D3 Human genes 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 108010060385 Cyclin B1 Proteins 0.000 description 3
- 102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108700008625 Reporter Genes Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000032823 cell division Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 210000002257 embryonic structure Anatomy 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- LIYGYAHYXQDGEP-UHFFFAOYSA-N firefly oxyluciferin Natural products Oc1csc(n1)-c1nc2ccc(O)cc2s1 LIYGYAHYXQDGEP-UHFFFAOYSA-N 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000504 luminescence detection Methods 0.000 description 3
- 239000013307 optical fiber Substances 0.000 description 3
- JJVOROULKOMTKG-UHFFFAOYSA-N oxidized Photinus luciferin Chemical compound S1C2=CC(O)=CC=C2N=C1C1=NC(=O)CS1 JJVOROULKOMTKG-UHFFFAOYSA-N 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000013268 sustained release Methods 0.000 description 3
- 239000012730 sustained-release form Substances 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108010058544 Cyclin D2 Proteins 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 230000004543 DNA replication Effects 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102100024185 G1/S-specific cyclin-D2 Human genes 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- YHIPILPTUVMWQT-UHFFFAOYSA-N Oplophorus luciferin Chemical compound C1=CC(O)=CC=C1CC(C(N1C=C(N2)C=3C=CC(O)=CC=3)=O)=NC1=C2CC1=CC=CC=C1 YHIPILPTUVMWQT-UHFFFAOYSA-N 0.000 description 2
- HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000000225 bioluminescence resonance energy transfer Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 150000002611 lead compounds Chemical class 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000016314 protein import into mitochondrial matrix Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- -1 CO 2 Chemical compound 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 108010060267 Cyclin A1 Proteins 0.000 description 1
- 108010060273 Cyclin A2 Proteins 0.000 description 1
- 108010060387 Cyclin B2 Proteins 0.000 description 1
- 102000002428 Cyclin C Human genes 0.000 description 1
- 108010068155 Cyclin C Proteins 0.000 description 1
- 108010058546 Cyclin D1 Proteins 0.000 description 1
- 102000004012 Cyclin G1 Human genes 0.000 description 1
- 108090000404 Cyclin G1 Proteins 0.000 description 1
- 108090000487 Cyclin G2 Proteins 0.000 description 1
- 102000004030 Cyclin G2 Human genes 0.000 description 1
- 108010068237 Cyclin H Proteins 0.000 description 1
- 108090000264 Cyclin I Proteins 0.000 description 1
- 102000003907 Cyclin I Human genes 0.000 description 1
- 108010068106 Cyclin T Proteins 0.000 description 1
- 102100025176 Cyclin-A1 Human genes 0.000 description 1
- 102100025191 Cyclin-A2 Human genes 0.000 description 1
- 102000015792 Cyclin-Dependent Kinase 2 Human genes 0.000 description 1
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 1
- 102100036883 Cyclin-H Human genes 0.000 description 1
- 102100024109 Cyclin-T1 Human genes 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 108090000331 Firefly luciferases Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 description 1
- 102100033201 G2/mitotic-specific cyclin-B2 Human genes 0.000 description 1
- 102100024114 G2/mitotic-specific cyclin-B3 Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000910528 Homo sapiens G2/mitotic-specific cyclin-B3 Proteins 0.000 description 1
- 241000254158 Lampyridae Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 208000009341 RNA Virus Infections Diseases 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 101150095095 TIMELESS gene Proteins 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000004993 emission spectroscopy Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000004904 long-term response Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000010852 mitochondrial transfer Methods 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012284 sample analysis method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Landscapes
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006273442A JP5424528B2 (ja) | 2006-10-04 | 2006-10-04 | 微弱光サンプルの解析方法および装置 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006273442A JP5424528B2 (ja) | 2006-10-04 | 2006-10-04 | 微弱光サンプルの解析方法および装置 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013143976A Division JP5726956B2 (ja) | 2013-07-09 | 2013-07-09 | 微弱光サンプルの解析方法および装置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008089521A JP2008089521A (ja) | 2008-04-17 |
| JP2008089521A5 JP2008089521A5 (enExample) | 2009-11-26 |
| JP5424528B2 true JP5424528B2 (ja) | 2014-02-26 |
Family
ID=39373824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006273442A Expired - Fee Related JP5424528B2 (ja) | 2006-10-04 | 2006-10-04 | 微弱光サンプルの解析方法および装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5424528B2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10401276B2 (en) | 2015-01-22 | 2019-09-03 | Olympus Corporation | Method for generating three-dimensional luminescence image, and imaging system |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5302063B2 (ja) * | 2009-03-24 | 2013-10-02 | オリンパス株式会社 | 微弱光および高強度光の画像を撮像可能な顕微鏡撮像装置 |
| JP5466976B2 (ja) * | 2010-03-19 | 2014-04-09 | オリンパス株式会社 | 顕微鏡システム、観察画像の表示方法、プログラム |
| JP5684020B2 (ja) * | 2011-03-24 | 2015-03-11 | オリンパス株式会社 | 正立型イメージング装置 |
| JP6253225B2 (ja) * | 2012-09-18 | 2017-12-27 | オリンパス株式会社 | 顕微鏡システムおよび顕微鏡観察方法 |
| JPWO2016189628A1 (ja) * | 2015-05-25 | 2018-03-08 | オリンパス株式会社 | 発光測定方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9014570D0 (en) * | 1990-06-29 | 1990-08-22 | Dixon Arthur E | Method for transmitted-light and reflected-light imaging |
| JP2000089124A (ja) * | 1998-09-14 | 2000-03-31 | Nikon Corp | 複合顕微鏡 |
| JP2000180728A (ja) * | 1998-12-10 | 2000-06-30 | Japan Science & Technology Corp | 二方位蛍光測光多光子励起レ―ザ顕微鏡 |
| JP3902939B2 (ja) * | 2001-10-26 | 2007-04-11 | 株式会社日立ハイテクノロジーズ | 標本中の微小領域測定装置及び方法 |
| JP4603283B2 (ja) * | 2004-04-14 | 2010-12-22 | オリンパス株式会社 | システム顕微鏡 |
| CN102156345A (zh) * | 2004-11-26 | 2011-08-17 | 奥林巴斯株式会社 | 发光试料摄像方法、发光细胞摄像方法及物镜 |
| CN102156346B (zh) * | 2005-02-21 | 2012-07-18 | 奥林巴斯株式会社 | 微弱光标本摄像单元及微弱光标本摄像装置 |
-
2006
- 2006-10-04 JP JP2006273442A patent/JP5424528B2/ja not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10401276B2 (en) | 2015-01-22 | 2019-09-03 | Olympus Corporation | Method for generating three-dimensional luminescence image, and imaging system |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008089521A (ja) | 2008-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5914561B2 (ja) | 測定装置および細胞解析方法 | |
| JP5726956B2 (ja) | 微弱光サンプルの解析方法および装置 | |
| JP5307539B2 (ja) | 生体試料撮像方法および生体試料撮像装置 | |
| CN102257379B (zh) | 分析荧光颗粒的方法及装置 | |
| Dana et al. | Sensitive red protein calcium indicators for imaging neural activity | |
| JP5058483B2 (ja) | 生体試料の長期間ないし連続的検出方法 | |
| EP1967886A1 (en) | Device and method for capturing image of a sample originating from organism | |
| US9664697B2 (en) | Green-to-red photo-convertible fluorescent calcium indicator | |
| CN101351735B (zh) | 获取生物源样本的图像的装置和方法 | |
| JP5424528B2 (ja) | 微弱光サンプルの解析方法および装置 | |
| JP6223037B2 (ja) | サバイビンについての細胞解析方法、並びにそれを利用した癌の解析方法および薬効のスクリーニング方法 | |
| JP5800462B2 (ja) | 光シグナル解析方法 | |
| Ulbrich | Counting molecules: Toward quantitative imaging | |
| Rajwa et al. | Single‐and two‐photon spectral imaging of intrinsic fluorescence of transformed human hepatocytes | |
| JP5124216B2 (ja) | 光シグナル観察方法および光シグナル観察システム | |
| US20240288371A1 (en) | Method for enhancing the photoresistance of a fluorescent protein and fluorescence microscopy system suitable for implementing said method | |
| JP5875773B2 (ja) | 紫外光測定方法 | |
| JP5226179B2 (ja) | 生物学的相互作用の解析方法および試薬キット | |
| JP2007199605A (ja) | 蛍光顕微鏡 | |
| JP2007085927A (ja) | 生体関連情報の画像化方法および生体内の相互作用を撮像する撮像方法、装置、装置を実行するためのプログラム、ソフトウェア、解析方法、試薬キット | |
| WO2016189628A1 (ja) | 発光測定方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091005 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091005 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110831 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110920 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111121 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120731 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130409 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130709 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20130826 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131029 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131126 |
|
| R151 | Written notification of patent or utility model registration |
Ref document number: 5424528 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |